CD8A and non-small cell lung carcinoma: In the advanced stage of NSCLC patients, CD3, CD4, CD8, and CD16 + 56+ T cells were significantly decreased, while D-Dimer was significantly increased in the ATB group (n = 95) than that in the non-ATB group (n = 104) (p < 0.05) (Table 6).